Hemostemix Inc V.HEM

Alternate Symbol(s): HMTXF

Healthcare Biotechnology

Hemostemix Inc. is a Canada-based autologous stem cell therapy company. The Company has developed, patented, and is scaling a patient’s blood-based stem cell therapeutics platform, which includes angiogenic cell precursors, neuronal cell precursors and cardiomyocyte cell precursors. The Company holds 87 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01, its lead clinical-stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. ACP-01 is in a Phase 2 clinical trial in Canada and the United States. Its technology includes methods for collecting the synergetic cell population and manufacturing a personalized regenerative therapy that can be administered to a patient within seven days of the initial cell collection. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd. and PreCerv Inc.

TSXV:HEM - Post by User

Hemostemix Inc

Bullboard Posts

Comment by kareadon Nov 15, 2009 3:54pm

203 Views

Post# 16488547

RE: buy or sell

Some good points tonyxdsun.

On bull side:
1) Bought out? I've never heard about so far. But it's possible.
2) Some good news, this wouldn't drive to too high
3) Shares buy back? they probably don't have cash to do so.
4) Technically bounce back?

The buyback story has been tossed around for quite a few years now. Will somebody try and take a run at it? There is no way to know, but it's certainly a possibility.

Yeah, some good news would give it a little pop, but it would have to be very good news in order to sustain it through the new year. (keep reading...), otherwise, it's just a selling opportunity.

There's no way they'll start buying share with company funds. Not when profit is so elusive.

There was already a technical bounce when it was oversold on the RSI last week. Then, the fluffy news release gave it the little bounce I was calling for. It is no longer oversold on the daily chart at this point in time. Even the weekly chart is not oversold, in fact the weekly chart just gave another sell signal on the MACD.

Bear side:
1) Year end sell for tax purpose.
2) Market pulls back
3) TA wise, no support.

Bingo! Especially on number 1. HEM is a huge candidate for tax loss selling. Taking into consideration the number of stocks that have done well this year (lots of them), the ones that didn't may be hit extra hard.